Michigan State spin-out Biophotonic raises $1m to support adaptive pulse compression technology.
Biophotonic Solutions (BSI), a spin-out of Michigan State University, has raised $1m in series A funding from the Michigan Angel Fund.
The company is commercialising ultra-fast pulse laser technology, known as a multiphoton intrapulse interference phase scan (MIPPS), currently used in scientific laboratories and make it available in medical and industrial applications.
The pulse lasers are already in use for cataract treatment, yet the complexity of the technology still makes them expensive and challenging to implement due to the need for a laser expert to continually configure their output.
BSI said that its MIPPS laser technology is autonomous and easy to use, which may ultimately be scalable and deployed in industrial and medical settings.
Kiyomi Monro, the recently joined chief executive of BSI, said: “The series A capital shores up BSI’s resources so that we can aggressively pursue OEM business in microscopy, semiconductor processing, and the development of cost-effective ultrafast lasers with adaptive capabilities. We look forward to complementing our established business, which is enabling femtosecond laser breakthroughs at leading universities, with new commercial opportunities.”
